Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Change in Account Payables (2020 - 2025)

RxSight's Change in Account Payables history spans 6 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 1800.0% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $627000.0, down 33.72%, while the annual FY2025 figure was $627000.0, 33.72% down from the prior year.
  • Change in Account Payables reached $2.2 million in Q4 2025 per RXST's latest filing, up from -$86000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q1 2025 to a low of -$3.7 million in Q2 2025.
  • Average Change in Account Payables over 5 years is $200650.0, with a median of $138500.0 recorded in 2023.
  • Peak YoY movement for Change in Account Payables: crashed 1779.21% in 2022, then soared 1800.0% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $101000.0 in 2021, then plummeted by 1779.21% to -$1.7 million in 2022, then soared by 90.68% to -$158000.0 in 2023, then skyrocketed by 173.42% to $116000.0 in 2024, then skyrocketed by 1800.0% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Change in Account Payables are $2.2 million (Q4 2025), -$86000.0 (Q3 2025), and -$3.7 million (Q2 2025).